Interleukin-1β (IL-1β) processing pathway

Science Signaling

Volumn 3, Issue 105, 2010, Pages

  Weber, Axel ^a   Wasiliew, Peter ^a   Kracht, Michael ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA; CARRIER PROTEIN; NLRP3 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; CELL ACTIVATION; CYTOKINE RELEASE; GENE EXPRESSION; HUMAN; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; IMMUNOLOGY; METABOLISM;

ANIMALS; CARRIER PROTEINS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKIN-1BETA; SIGNAL TRANSDUCTION;

EID: 77952296338     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.3105cm2     Document Type: Review

References (38)

1. E. Meylan, J. Tschopp, M. Karin, Intracellular pattern recognition receptors in the host response. Nature 442, 39-44 (2006).
2. F. Martinon, A. Mayor, J. Tschopp, The inflammasomes: Guardians of the body. Annu. Rev. Immunol. 27, 229-265 (2009).
3. F. Martinon, V. Pétrilli, A. Mayor, A. Tardivel, J. Tschopp, Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241 (2006).
4. V. Pétrilli, S. Papin, C. Dostert, A. Mayor, F. Martinon, J. Tschopp, Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 14, 1583-1589 (2007).
5. S. Mariathasan, D. S.Weiss, K. Newton, J. McBride, K. O'Rourke, M. Roose-Girma, W. P. Lee, Y. Weinrauch, D. M. Monack, V. M. Dixit, Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232 (2006).
6. A. Halle, V. Hornung, G. C. Petzold, C. R. Stewart, B. G. Monks, T. Reinheckel, K. A. Fitzgerald, E. Latz, K. J. Moore, D. T. Golenbock, The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9, 857-865 (2008).
7. C. Dostert, V. Pétrilli, R. Van Bruggen, C. Steele, B. T. Mossman, J. Tschopp, Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674-677 (2008).
8. D. A. Muruve, V. Pétrilli, A. K. Zaiss, L. R. White, S. A. Clark, P. J. Ross, R. J. Parks, J. Tschopp, The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452, 103-107 (2008).
9. A. Mayor, F. Martinon, T. De Smedt, V. Pétrilli, J. Tschopp, A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses. Nat. Immunol. 8, 497-503 (2007).
10. S. C. Eisenbarth, O. R. Colegio, W. O'Connor, F. S. Sutterwala, R. A. Flavell, Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453, 1122-1126 (2008).
11. V. Hornung, F. Bauernfeind, A. Halle, E. O. Samstad, H. Kono, K. L. Rock, K. A. Fitzgerald, E. Latz, Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847-856 (2008).
12. S. L. Cassel, S. C. Eisenbarth, S. S. Iyer, J. J. Sadler, O. R. Colegio, L. A.Tephly, A. B. Carter, P. B. Rothman, R. A. Flavell, F. S. Sutterwala, The Nalp3 inflammasome is essential for the development of silicosis. Proc. Natl. Acad. Sci. U.S.A. 105, 9035-9040 (2008).
13. F. S. Sutterwala, Y. Ogura, M. Szczepanik, M. Lara-Tejero, G. S. Lichtenberger, E. P. Grant, J. Bertin, A. J. Coyle, J. E. Galán, P.W. Askenase, R. A. Flavell, Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1.Immunity 24, 317-327 (2006).
14. L. Feldmeyer, M. Keller, G. Niklaus, D. Hohl, S. Werner, H. D. Beer, The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr. Biol. 17, 1140-1145 (2007).
15. F. Martinon, K. Burns, J. Tschopp, The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proILbeta. Mol. Cell 10, 417-426 (2002).
16. L. Agostini, F. Martinon, K. Burns, M. F. McDermott, P. N. Hawkins, J. Tschopp, NALP3 forms an IL-1 beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20, 319-325 (2004).
17. E. Aganna, F. Martinon, P. N. Hawkins, J. B. Ross, D. C. Swan, D. R. Booth, H. J. Lachmann, R. Gaudet, P. Woo, C. Feighery, F. E. Cotter, M. Thome, G. A. Hitman, J. Tschopp, M. F. McDermott, Association of mutations in the NALP3/CIAS1/ PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum. 46, 2445-2452 (2002).
18. D. P. Cerretti, C. J. Kozlosky, B. Mosley, N. Nelson, K. Van Ness, T. A. Greenstreet, C. J. March, S. R. Kronheim, T. Druck, L. A. Cannizzaro, K. Huebner, R. A. Black, Molecular cloning of the interleukin-1 beta converting enzyme. Science 256, 97-100 (1992).
19. N. A. Thornberry, H. G. Bull, J. R. Calaycay, K. T. Chapman, A. D. Howard, M. J. Kostura, D. K. Miller, S. M. Molineaux, J. R.Weidner, J. Aunins, K. O. Elliston, J. M. Ayala, F. J. Casano, J. Chin, G. J.-F. Ding, L. A. Egger, E. P. Gaffney, G. Limjuco, O. C. Palyha, S. M. Raju, A. M. Rolando, J. P. Salley, T.-T. Yamin, T. D. Lee, J. E. Shively, M. MacCross, R. A. Mumford, J. A. Schmidt, M. J. Tocci, A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356, 768-774 (1992).
20. P. Li, H. Allen, S. Banerjee, S. Franklin, L. Herzog, C. Johnston, J. McDowell, M. Paskind, L. Rodman, J. Salfeld, E. Towne, D. Tracey, S. Wardwell, F.-Y. Wei, W. Wong, R. Kamen, T. Seshadri, Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 80, 401-411 (1995).
21. K. Kuida, J. A. Lippke, G. Ku, M. W. Harding, D. J. Livingston, M. S. Su, R. A. Flavell, Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267, 2000-2003 (1995).
22. F. Martinon, O. Gaide, V. Pétrilli, A. Mayor, J. Tschopp, NALP inflammasomes: A central role in innate immunity. Semin. Immunopathol. 29, 213-229 (2007).
23. J. A. Duncan, D. T. Bergstralh, Y. Wang, S. B. Willingham, Z. Ye, A. G. Zimmermann, J. P. Ting, Cryopyrin/ NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc. Natl. Acad. Sci. U.S.A. 104, 8041-8046 (2007).
24. K. P. Wilson, J.-A. F. Black, J. A. Thomson, E. E. Kim, J. P. Griffith, M. A. Navia, M. A. Murcko, S. P. Chambers, R. A. Aldape, S. A. Raybuck, D. J. Livingston, Structure and mechanism of interleukin-1 beta converting enzyme. Nature 370, 270-275 (1994).
25. A. D. Howard, M. J. Kostura, N. Thornberry, G. J. Ding, G. Limjuco, J. Weidner, J. P. Salley, K. A. Hogquist, D. D. Chaplin, R. A. Mumford, IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha. J. Immunol. 147, 2964-2969 (1991).
26. C. A. Gabel, P2 purinergic receptor modulation of cytokine production. Purinergic Signal. 3, 27-38 (2007).
27. J.M. Labasi, N. Petrushova, C. Donovan, S. McCurdy, P. Lira, M. M. Payette, W. Brissette, J. R. Wicks, L. Audoly, C. A. Gabel, Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J. Immunol. 168, 6436-6445 (2002).
28. M. Solle, J. Labasi, D. G. Perregaux, E. Stam, N. Petrushova, B. H. Koller, R. J. Griffiths, C. A. Gabel, Altered cytokine production in mice lacking P2X(7) receptors. J. Biol. Chem. 276, 125-132 (2001).
29. D. G. Perregaux, P. McNiff, R. Laliberte, M. Conklyn, C. A. Gabel, ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood. J. Immunol. 165, 4615-4623 (2000).
30. M. G. Netea, C. A. Nold-Petry, M. F. Nold, L. A. Joosten, B. Opitz, J. H. van der Meer, F. L. van de Veerdonk, G. Ferwerda, B. Heinhuis, I. Devesa, C. J. Funk, R. J. Mason, B. J. Kullberg, A. Rubartelli, J.W. van der Meer, C. A. Dinarello, Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113, 2324-2335 (2009).
31. T. D. Kanneganti, N. Ozören, M. Body-Malapel, A. Amer, J. H. Park, L. Franchi, J. Whitfield, W. Barchet, M. Colonna, P.Vandenabeele, J. Bertin, A. Coyle, E. P. Grant, S. Akira, G. Núñez, Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440, 233-236 (2006).
32. M. Yamamoto, K. Yaginuma, H. Tsutsui, J. Sagara, X. Guan, E. Seki, K. Yasuda, M. Yamamoto, S. Akira, K. Nakanishi, T. Noda, S. Taniguchi, ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules. Genes Cells 9, 1055-1067 (2004).
33. S. Mariathasan, K. Newton, D. M. Monack, D.Vucic, D. M. French, W. P. Lee, M. Roose-Girma, S. Erickson, V. M. Dixit, Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213-218 (2004).
34. S. Farasat, I. Aksentijevich, J. R. Toro, Autoinflammatory diseases: Clinical and genetic advances. Arch. Dermatol. 144, 392-402 (2008).
35. C. A. Dinarello, Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519-550 (2009).
36. A. So, T. De Smedt, S. Revaz, J. Tschopp, A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res. Ther. 9, R28 (2007).
37. R. Goldbach-Mansky, S. D. Shroff, M. Wilson, C. Snyder, S. Plehn, B. Barham, T. H. Pham, F. Pucino, R. A. Wesley, J. H. Papadopoulos, S. P. Weinstein, S. J. Mellis, D. L. Kastner, A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome. Arthritis Rheum. 58, 2432-2442 (2008).
38. H. M. Hoffman, M. L. Throne, N. J. Amar, M. Sebai, A. J. Kivitz, A. Kavanaugh, S. P. Weinstein, P. Belomestnov, G. D.Yancopoulos, N. Stahl, S. J. Mellis, Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebocontrolled studies. Arthritis Rheum. 58, 2443-2452